Genetic data will be safeguarded with 23andMe sale, drugmaker vows – The Washington Post
Business News
- Genetic data will be safeguarded with 23andMe sale, drugmaker vows The Washington Post
- Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale GlobeNewswire
- 23andMe To Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million The New York Times
- Struggling DNA testing firm 23andMe to be bought for $256m BBC
- Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million WSJ
Source: Business News
